Zimmer Biomet Holdings (ZBH) Stock Price, Quote & News

Company Profile

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising...

Industry: Medical Devices

Sector: Healthcare

Phone: 574 373 3333

Website: www.zimmerbiomet.com

Address:

345 East Main Street, Warsaw, United States

Reversal_Levels Jun. 5 at 10:31 AM

Trade setup. We have a buy signal for $ZBH and will be adding it to our trading journal coverage. Defensive names have been out of favor for some time. That too will change some day. Here is the chart. Even in gradually declining stocks like this one you can pick up good short term trades when PuLL is low and MoM is bottoming. More: https://blog.reversallevels.com/2026/06/trading-journal-june-5-2026.html

0 · Reply

supplySHOCK Jun. 4 at 11:11 AM

$IMO $EME $GSK $ZBH yall

0 · Reply

BillionerOfKing Jun. 1 at 9:05 PM

$ZBH Current Stock Price: $82.93 Contracts to trade: $85.0 ZBH Jun 18 2026 Call Entry: $1.35 Exit: $2.09 ROI: 55% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

SuperGreenToday May. 27 at 7:43 AM

$ZBH Share Price: $84.43 Contract Selected: Dec 18, 2026 $85 Calls Buy Zone: $6.07 – $7.50 Target Zone: $10.77 – $13.16 Potential Upside: 67% ROI Time to Expiration: 204 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

IncognitoBull May. 16 at 11:43 AM

$NMTC $ZBH has given NMTC $8M in licensing fees as milestones were achieved with 3M in 2025. One milestone award was left, $1M if certain sales goals were achieved. The latest filing states that level was not achieved. The company is not rushing this out, it is brain and face ablation. Careful adoption.

0 · Reply

BillionerOfKing May. 11 at 3:39 PM

$ZBH Current Stock Price: $79.78 Contracts to trade: $80.0 ZBH May 15 2026 Call Entry: $0.95 Exit: $1.75 ROI: 85% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

CapitalMonk May. 11 at 12:04 PM

$ZBH Price: $82.33 (-1.25%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±4.43% RSI: 22.5 | Momentum: Strong Downside Volume: -22.7% vs avg Volatility: 2.85% Support: $79.83 | Resistance: $97.81 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

BillionerOfKing May. 6 at 10:19 PM

$ZBH Current Stock Price: $82.85 Contracts to trade: $85.0 ZBH May 15 2026 Call Entry: $0.60 Exit: $0.77 ROI: 29% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

d5stocks May. 1 at 4:35 PM

$SYK Stock trading at PE 20 ( with guidance at 14.90 EPS on low side). this is on Sale. Great entry. predicting .. will bounce back ( similar to $ZBH after earnings)

0 · Reply

BullYa Apr. 30 at 12:36 PM

$ZBH Vanguard Group Inc. Buys 192,517 Shares of Zimmer Biomet Holdings, Inc.

0 · Reply

Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

2026-05-28T12:12:32.000Z - 9 days ago

Zimmer Biomet price target lowered to $93 from $95 at Citi

May 22, 2026, 4:30 PM EDT - 14 days ago

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026

May 22, 2026, 9:30 AM EDT - 15 days ago

Zimmer Biomet Holdings Transcript: AGM 2026

May 13, 2026, 11:40 AM EDT - 23 days ago

Zimmer Biomet Holdings Transcript: Bank of America Global Healthcare Conference 2026

2026-05-12T11:26:51.000Z - 25 days ago

Zimmer Biomet increases share repurchase program by $250M

May 12, 2026, 6:30 AM EDT - 25 days ago

Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End

May 6, 2026, 7:30 AM EDT - 4 weeks ago

Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference

2026-04-29T16:31:33.000Z - 5 weeks ago

Zimmer Biomet price target lowered to $92 from $98 at Truist

2026-04-29T14:03:58.000Z - 5 weeks ago

Zimmer Biomet price target lowered to $95 from $100 at JPMorgan

2026-04-29T13:14:47.000Z - 5 weeks ago

Zimmer Biomet price target lowered to $105 from $110 at Stifel

2026-04-29T12:45:35.000Z - 5 weeks ago

Zimmer Biomet price target lowered to $83 from $93 at Canaccord

2026-04-29T11:04:46.000Z - 5 weeks ago

Zimmer Biomet price target lowered to $92 from $100 at Baird

2026-04-29T10:58:25.000Z - 5 weeks ago

Zimmer Biomet price target lowered to $95 from $98 at Citi

2026-04-29T10:00:35.000Z - 5 weeks ago

Zimmer Biomet price target lowered to $105 from $120 at Citizens

2026-04-29T09:54:00.000Z - 5 weeks ago

Zimmer Biomet price target lowered to $94 from $100 at Barclays

Apr 28, 2026, 8:30 AM EDT - 5 weeks ago

Zimmer Biomet Holdings Earnings Call Transcript: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 5 weeks ago

Zimmer Biomet Holdings Earnings release: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 5 weeks ago

Zimmer Biomet Holdings Quarterly report: Q1 2026

Apr 28, 2026, 8:29 AM EDT - 5 weeks ago

Medical device maker Zimmer Biomet raises annual profit forecast, announces CFO departure

2026-04-28T10:31:49.000Z - 5 weeks ago

Zimmer Biomet CFO Suketu Upadhyay to depart

Apr 28, 2026, 6:30 AM EDT - 5 weeks ago

Zimmer Biomet Announces First Quarter 2026 Financial Results

Apr 28, 2026, 6:29 AM EDT - 5 weeks ago

Zimmer Biomet Announces Chief Financial Officer Transition

2026-04-13T11:35:17.000Z - 7 weeks ago

Zimmer Biomet initiated with a Market Perform at Leerink

Apr 9, 2026, 7:30 AM EDT - 2 months ago

Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results

2026-04-07T11:57:33.000Z - 2 months ago

Zimmer Biomet names new Chief Science, Technology and Medical Affairs Officer

Apr 7, 2026, 7:30 AM EDT - 2 months ago

Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer

Apr 1, 2026, 8:00 AM EDT - 2 months ago

Zimmer Biomet Holdings Proxy statement: Proxy filing

Apr 1, 2026, 8:00 AM EDT - 2 months ago

Zimmer Biomet Holdings Proxy statement: Proxy filing

Mar 6, 2026, 9:00 AM EST - 3 months ago

Zimmer Biomet Holdings, Inc. Investigated by the Portnoy Law Firm

Feb 25, 2026, 7:06 AM EST - 3 months ago

Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting

Feb 23, 2026, 7:00 AM EST - 3 months ago

Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026

Feb 10, 2026, 8:30 AM EST - 4 months ago

Zimmer Biomet Holdings Earnings Call Transcript: Q4 2025

Feb 10, 2026, 8:30 AM EST - 4 months ago

Zimmer Biomet Holdings Annual report: Q4 2025

Feb 10, 2026, 8:30 AM EST - 4 months ago

Zimmer Biomet Holdings Annual report: Q4 2025

Feb 10, 2026, 8:30 AM EST - 4 months ago

Zimmer Biomet Holdings Earnings release: Q4 2025

Feb 10, 2026, 8:18 AM EST - 4 months ago

Zimmer Biomet beats quarterly estimates on strong hips, knees device demand

Feb 10, 2026, 6:30 AM EST - 4 months ago

Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results

Jan 15, 2026, 7:30 AM EST - 5 months ago

Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results

Jan 13, 2026, 11:15 AM EST - 5 months ago

Zimmer Biomet Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 11:15 AM EST - 5 months ago

Zimmer Biomet Holdings Slides: 44th Annual J.P. Morgan Healthcare Conference

Dec 22, 2025, 7:30 AM EST - 5 months ago

Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 17, 2025, 7:00 AM EST - 6 months ago

Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2025

Dec 16, 2025, 7:30 AM EST - 6 months ago

Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data to Patients and Surgeons to Help Improve Joint Procedure Recovery

Nov 18, 2025, 7:00 AM EST - 7 months ago

Zimmer Biomet Holdings Transcript: Jefferies London Healthcare Conference 2025

Nov 17, 2025, 8:55 AM EST - 7 months ago

Could Zimmer Biomet Stock Be Your Next Buy?

Nov 14, 2025, 7:30 AM EST - 7 months ago

Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology

Nov 7, 2025, 7:30 AM EST - 7 months ago

Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London

Nov 6, 2025, 11:15 AM EST - 7 months ago

Time To Buy Zimmer Biomet Stock?

Nov 5, 2025, 12:00 PM EST - 7 months ago

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why.

Nov 5, 2025, 8:30 AM EST - 7 months ago

Zimmer Biomet Holdings Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:30 AM EST - 7 months ago

Zimmer Biomet Holdings Quarterly report: Q3 2025

Nov 5, 2025, 8:30 AM EST - 7 months ago

Zimmer Biomet Holdings Earnings release: Q3 2025

Nov 5, 2025, 8:04 AM EST - 7 months ago

Zimmer cuts 2025 organic sales growth forecast on weakness in international markets

Nov 5, 2025, 6:30 AM EST - 7 months ago

Zimmer Biomet Announces Third Quarter 2025 Financial Results

Oct 28, 2025, 7:30 AM EDT - 7 months ago

Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System

Oct 21, 2025, 7:30 AM EDT - 8 months ago

Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting

Oct 8, 2025, 7:30 AM EDT - 8 months ago

Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases

Oct 7, 2025, 9:00 AM EDT - 8 months ago

Zimmer Biomet Completes Acquisition of Monogram Technologies

Oct 6, 2025, 8:00 AM EDT - 8 months ago

I2Pure Celebrates Zimmer Biomet's Historic Approval of Iodine-Treated Implant System & Confirms AAHKS Attendance

Oct 3, 2025, 7:30 AM EDT - 8 months ago

Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2025 Financial Results

Sep 25, 2025, 4:30 PM EDT - 9 months ago

Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System

Sep 8, 2025, 8:30 AM EDT - 9 months ago

Zimmer Biomet Holdings Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 4, 2025, 4:05 PM EDT - 9 months ago

Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference

Aug 28, 2025, 7:30 AM EDT - 10 months ago

Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care

Aug 27, 2025, 7:00 AM EDT - 10 months ago

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025

Aug 25, 2025, 7:30 AM EDT - 10 months ago

Zimmer Biomet to Present at the Annual Morgan Stanley Healthcare Conference

Aug 12, 2025, 11:20 AM EDT - 10 months ago

4 Stocks to Buy From a Top-Performing Fund Manager

AMZN CRM NKE

Aug 7, 2025, 8:30 AM EDT - 10 months ago

Zimmer Biomet Holdings Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 10 months ago

Zimmer Biomet Holdings Quarterly report: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 10 months ago

Zimmer Biomet Holdings Earnings release: Q2 2025

Aug 7, 2025, 8:09 AM EDT - 10 months ago

Zimmer Biomet raises annual profit forecast on strong demand for medical devices

Jul 16, 2025, 11:36 AM EDT - 11 months ago

MONOGRAM TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Monogram Technologies Inc. - MGRM

MGRM

Jul 11, 2025, 2:21 PM EDT - 11 months ago

Final Trades: Uber, Delta, Zimmer Holdings and Boeing

BA UBER DAL

Jul 9, 2025, 7:30 AM EDT - 11 months ago

Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2025 Financial Results

Jun 26, 2025, 11:46 AM EDT - 1 year ago

New vaccine panel meeting underway

BDX BMY MRK UNH

Jun 9, 2025, 9:20 AM EDT - 1 year ago

Zimmer Biomet Holdings Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 30, 2025, 7:00 AM EDT - 1 year ago

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025

Reversal_Levels Jun. 5 at 10:31 AM

0 · Reply

supplySHOCK Jun. 4 at 11:11 AM

$IMO $EME $GSK $ZBH yall

0 · Reply

BillionerOfKing Jun. 1 at 9:05 PM

0 · Reply

SuperGreenToday May. 27 at 7:43 AM

0 · Reply

IncognitoBull May. 16 at 11:43 AM

0 · Reply

BillionerOfKing May. 11 at 3:39 PM

0 · Reply

CapitalMonk May. 11 at 12:04 PM

0 · Reply

BillionerOfKing May. 6 at 10:19 PM

0 · Reply

d5stocks May. 1 at 4:35 PM

$SYK Stock trading at PE 20 ( with guidance at 14.90 EPS on low side). this is on Sale. Great entry. predicting .. will bounce back ( similar to $ZBH after earnings)

0 · Reply

BullYa Apr. 30 at 12:36 PM

$ZBH Vanguard Group Inc. Buys 192,517 Shares of Zimmer Biomet Holdings, Inc.

0 · Reply

GABIRODZ01 Apr. 30 at 11:12 AM

$ZBH bought at $80.18. Let’s see what happens.

0 · Reply

_Crim_Jamer_ Apr. 29 at 11:46 PM

$ZBH share price..

0 · Reply

GABIRODZ01 Apr. 29 at 10:04 PM

$ZBH Let’s see if it bites at $79.85

0 · Reply

BullYa Apr. 29 at 7:51 PM

$ZBH panicking oversold for nothing 😂

0 · Reply

STOCKPICKERTRADER Apr. 29 at 2:28 PM

$ZBH beat on the EPS/Revenues and sector weakness keeping it subdued imo.... for now

0 · Reply

STOCKPICKERTRADER Apr. 29 at 2:17 PM

$ZBH started position to bottom fish

0 · Reply

pooldude44646 Apr. 29 at 1:12 PM

$ZBH Zimmer Biomet CFO departs for new job Suketu Upadhyay is headed to biopharma company Incyte. Paul Stellato will step into the CFO role on an interim basis.

0 · Reply

BullYa Apr. 29 at 12:06 PM

$ZBH ✅ should be $100 by now with good earnings. 🤷‍♂️

0 · Reply

BullYa Apr. 29 at 11:58 AM

$ZBH beat earnings ✅💨🛫 It’s a buy ✅

0 · Reply

BullYa Apr. 28 at 9:39 PM

$ZBH beats earnings ✅💨🛫

0 · Reply

BullYa Apr. 28 at 9:19 PM

$ZBH $85 soon ✅

0 · Reply

BullYa Apr. 28 at 8:48 PM

$ZBH ✅priced in ok bet now.

0 · Reply

Market Cap	16.44B
Revenue (ttm)	8.23B
Net Income (ttm)	705.20M
EPS (ttm)	N/A
PE Ratio	9.88
Forward PE	9.87
Profit Margin	8.57%
Debt to Equity Ratio	0.59

Volume	1,963,633
Avg Vol	2,360,902
Day's Range	N/A - N/A
Shares Out	193.46M
Stochastic %K	80%
Beta	0.47
Analysts	Sell
Price Target	$98.24